Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.
about
Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.Proteomic analysis of Staphylococcus aureus biofilm cells grown under physiologically relevant fluid shear stress conditions.Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Scaffold-based anti-infection strategies in bone repair.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilmsAntimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.Real-Time Monitoring of nfxB Mutant Occurrence and Dynamics in Pseudomonas aeruginosa Biofilm Exposed to Subinhibitory Concentrations of CiprofloxacinPhenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.Biofilm-specific antibiotic resistance.The problems of antibiotic resistance in cystic fibrosis and solutions.Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.Studying the effect of administration route and treatment dose on the selection of enrofloxacin resistance in commensal Escherichia coli in broilers.Spatial Organization Plasticity as an Adaptive Driver of Surface Microbial Communities.Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosaRelative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing.Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis.Multiscale Evolutionary Dynamics of Host-Associated Microbiomes.
P2860
Q31138535-63A2EE9D-EEFB-4942-BCBA-46E575922682Q33578359-5FBEBB3C-5A54-4C3A-B00E-7E6D73D9F1E8Q34082906-4A9AABA2-951E-44B6-8F6D-B6CBB4E228EAQ34297656-5E1AFEF5-35FF-4FB6-9D96-8BCF7F2D709BQ35235414-32E9C155-CD25-4FA9-95FC-221254D7C86CQ35482558-E3627615-BEF1-4FA2-BB52-5C58414E9F0CQ35580712-AF90FBA5-59BD-4363-884A-522B7C72DB08Q35746192-AA8D9CB4-B855-4A33-A217-6769974CC57DQ35933495-0DE674AE-988B-47E8-AA0F-93587DDD6D2DQ35939649-9D6284B4-5391-4B7B-AAD6-39F58D6701E5Q36228925-3387A19C-1878-448F-B447-B424114FD2BFQ38006032-269F257F-5648-42AD-9D7A-D54956979AE8Q38041189-DB06A93A-C12D-49C4-9139-18ED446EB3D2Q38300820-EC6D5918-80DA-4D08-BA3A-F150ED37137CQ38810304-BBC2AE73-5F6E-432B-9CF5-C7138761AD03Q40238353-8DF33E9F-1BE1-43F1-9611-44F96A85EDF3Q41062024-7091B423-9004-4537-9270-601283DAB858Q42572942-7DFC37CD-F9A9-4DAB-BF71-230BE18E5266Q46655216-C37C6E7C-DCEB-467D-B51E-FA8DD85002EFQ47877807-58591557-7DB5-4F3E-AAB4-6512A5F7F63AQ51148518-DE3415FA-8D82-4680-804B-F71CFD3F4F53
P2860
Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dynamics of mutator and antibi ...... aeruginosa biofilm treatment.
@ast
Dynamics of mutator and antibi ...... aeruginosa biofilm treatment.
@en
type
label
Dynamics of mutator and antibi ...... aeruginosa biofilm treatment.
@ast
Dynamics of mutator and antibi ...... aeruginosa biofilm treatment.
@en
prefLabel
Dynamics of mutator and antibi ...... aeruginosa biofilm treatment.
@ast
Dynamics of mutator and antibi ...... aeruginosa biofilm treatment.
@en
P2860
P921
P356
P1476
Dynamics of mutator and antibi ...... s aeruginosa biofilm treatment
@en
P2093
Antonio Oliver
José L Pérez
P2860
P304
P356
10.1128/AAC.00617-11
P407
P577
2011-08-22T00:00:00Z